Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Drug Concentrations: Measurements

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Annual Banned-Substance Review 18th Edition-Analytical Approaches in Human Sports Drug Testing 2024/2025.

Drug testing and analysis·2026

Same author

Multi-Detector Helical Computed Tomography, Transrectal Ultrasonography, and Histology of the Sacroiliac Joint: A Comparative Study in Adult Warmblood Horse Cadavers.

Animals : an open access journal from MDPI·2025

Same author

Detection of the GH analogue somatrogon in doping control urine samples by means of LC-HRMS/MS.

Scientific reports·2025

Same author

Annual Banned-Substance Review 17th Edition-Analytical Approaches in Human Sports Drug Testing 2023/2024.

Drug testing and analysis·2024

Same author

Long-Term Excretion of Roxadustat in Urine.

Drug testing and analysis·2024

Same author

Investigations into the Concentrations and Metabolite Profiles of Doping Agents and Antidepressants in Human Seminal Fluid Using Liquid Chromatography-Mass Spectrometry.

Drug metabolism and disposition: the biological fate of chemicals·2024

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction

Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction

Published on: April 10, 2026

[Doping control activities in Germany 1989-2006].

Mario Thevis¹, Hans Geyer, Wilhelm Schänzer

¹Zentrum für Präventive Dopingforschung--Institut für Biochemie, Deutsche Sporthochschule Köln, Carl-Diem-Weg 6, 50933 Köln. thevis@dshs-koeln.de

Medizinische Klinik (Munich, Germany : 1983)

|May 20, 2008

Summary

German doping controls increased significantly from 1989-2006, especially out-of-competition testing. However, per-capita analyses revealed disparities between federations, necessitating a review of national anti-doping efforts.

More Related Videos

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Investigations on the Ga(III) Complex of EOB-DTPA and Its ⁶⁸Ga Radiolabeled Analogue

Published on: August 17, 2016

Related Experiment Videos

Last Updated: Jul 5, 2026

Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction

Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction

Published on: April 10, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Investigations on the Ga(III) Complex of EOB-DTPA and Its ⁶⁸Ga Radiolabeled Analogue

Published on: August 17, 2016

Area of Science:

Sports Science
Anti-Doping Research
Public Health

Background:

Doping controls are essential for maintaining fair play and the integrity of sports.
Evaluating national anti-doping strategies provides insights into their effectiveness and evolution.
Germany's anti-doping efforts between 1989 and 2006 offer a case study for analysis.

Purpose of the Study:

To evaluate the development of German anti-doping activities over an 18-year period.
To analyze trends in both in-competition and out-of-competition doping controls.
To identify discrepancies in anti-doping efforts across different sports federations.

Main Methods:

Data collection on the quantity of doping controls conducted by federations and anti-doping organizations.
Analysis of the ratio between in-competition and out-of-competition tests.
Calculation of per-capita tests based on the number of athletes per squad.
Summarization of adverse analytical findings.

Main Results:

A consistent increase in overall anti-doping efforts was observed during the study period.
A notable rise in the number of out-of-competition controls was a key trend.
Significant variations in per-capita testing rates were identified among different federations.
Adverse analytical findings, while not detailed, were part of the summarized data.

Conclusions:

German anti-doping efforts showed a positive trend in volume and focus on out-of-competition testing.
Discrepancies in per-capita testing highlight potential inequalities in anti-doping resource allocation.
Recent doping scandals underscore the need for a critical reassessment of national anti-doping strategies.